Advertisement

Ewing-Sarkom

  • H. Jürgens

Zusammenfassung

Knochentumor mit intramedullärer, gewöhnlich diaphysärer Ausdehnung und transkortikalem Weichteildurchbruch, von gewöhnlich harter Konsistenz mit weicheren hämorrhagischen und zystisch degenerierten Arealen. Histologisch uniformes klein-, blau-, rundzelliges Bild mit mäßiger Mitosenzahl. Vereinzelt unvollständig pseudorosettenartige Anordnung der Tumorzellen. In der PAS-Färbung gewöhnlich Nachweis reichlicher intrazytoplasmatischer Glykogenablagerungen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bacci G, Toni A, Avella M et al. (1989) Long-term results in 144 localized Ewing’s sarcoma patients treated with combined therapy. Cancer 63: 1477–1486PubMedCrossRefGoogle Scholar
  2. 2.
    Burdach St, Jürgens H, Van Valen F, Zessack N, Dilloo D, Hanenberg H, Pennings C, Ladenstein R, Gadner H, Göbel U (1992) Myeloablation, stem cell grafting and cytokine therapy in poor prognosis Ewing sarcoma: current concepts and future directions. Bone Marrow Transplantation 10: 18Google Scholar
  3. 3.
    Burgert EO, Nesbit ME, Garnsey LA et al. (1990) Multimodal therapy for the management of nonpelvic localized Ewing’s sarcoma of bone: Intergroup Study IESS-KK. J Clin Oncol 8: 1514–1524PubMedGoogle Scholar
  4. 4.
    Campanacci M (1990) Ewing’s sarcoma. In: Campanacci M (ed) Bone and soft tissue tumors, Springer, Vienna New York, pp 309–538Google Scholar
  5. 5.
    Deméocq F, Carton P, Patte C, Oberlin O, Sarrazin D, Lemerle J (1984) Traitement du sarcome d’Ewing par chimiotherapie initiale intensive. Press Med 13: 717–721Google Scholar
  6. 6.
    Dockhorn-Dworniczak B, Schäfer RL, Dantcheva R, Blasius S, van Valen F, Burdach S, Winkelmann W, Jürgens H, Böcker W (1994) Molekulargenetischer Nachweis der t(11;22)(g24; q12)-Translokation in Ewing-Sarkomen und malignen peripheren neuroektodermalen Tumoren (MPNT). Pathologe 15: 103–112PubMedCrossRefGoogle Scholar
  7. 7.
    Donaldson SS (1981) A story of continuing success — radiotherapy for Ewing’s sarcoma. Int J Radiat Oncol Biol Phys 7: 279–281PubMedCrossRefGoogle Scholar
  8. 8.
    Dunst J, Sauer R, Burgers JMV, Hawlizcek R, Kürten R, Müller RP, Wannenmacher M, Jürgens H (1988) Radiotherapie beim Ewing-Sarkom: aktuelle Ergebnisse der GPO Studien CESS 81 und CESS 86. Klin Pädiatr 200: 261–266PubMedCrossRefGoogle Scholar
  9. 9.
    Dunst J, Sauer R, Burgers JMV, Hawliczek R, Kürten R, Winkelmann W, Salzer-Kuntschik M, Müschenich M, Jürgens H, and the Cooperative Ewing’s Sarcoma Study Group (1991) Radiation therapy as local treatment in Ewing’s sarcoma. Results of the Cooperative Ewing’s Sarcoma Studies CESS 81 and CESS 86. Cancer 67: 2818–2825PubMedCrossRefGoogle Scholar
  10. 10.
    Gasparini M, Lombardi F, Gianni C, Fossati-Bellani F (1981) Localized Ewing’s sarcoma: results of integrated therapy and analysis of failures. Eur J Cancer Clin Oncol 17: 1205–1209PubMedCrossRefGoogle Scholar
  11. 11.
    Glass AG, Fraumeni Jr JF (1970) Epidemiology of bone cancer in children JNCI 44: 187–199Google Scholar
  12. 12.
    Hayes FA, Thompson EI, Meyer WH et al. (1989) Therapy for localized Ewing’s sarcoma of bone. J Clin Oncol 7: 208–213PubMedGoogle Scholar
  13. 13.
    Huvos AG (1991) Ewing’s sarcoma. In: Huvos AG (ed): Bone tumors. Diagnosis, treatment and prognosis. Saunders, Philadelphia, pp 523–552Google Scholar
  14. 14.
    Issels RR, Mittermüller J, Gerl A, Simon W, Ortmaier A, Denzlinger C, Sauer H, Wilmanns W (1991) Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients. J Cancer Res Clin Oncol 117: 141–147CrossRefGoogle Scholar
  15. 15.
    Jürgens H, Exner U, Gadner H et al. (1988) Multidisciplinary treatment of Ewing’s sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer 61: 23–32PubMedCrossRefGoogle Scholar
  16. 16.
    Jürgens H, Winkler K, Göbel U (1992) Bone tumours. In: Plowman PN, Pinkerton CR (eds) Paediatric Oncology. Clinical practice and controversies. Chapman & Hall Medical, London New York Tokyo Melbourne Madras, pp 325–350Google Scholar
  17. 17.
    Jürgens H, Donaldson SS, Göbel U (1992) Ewing’s Sarcoma. In: Voûte PA, Barrett A, Lemerle J (eds): Cancer in children. Springer-Verlag, Berlin Heidelberg New York, pp 295–313CrossRefGoogle Scholar
  18. 18.
    Jürgens H, Craft AW (1992) European Intergroup Cooperative Ewing’s Sarcoma Study, Study manualGoogle Scholar
  19. 19.
    Jürgens H (1994) Ewing’s sarcoma and peripheral primitive neuroectodermal tumor. Current Opinion in Oncology 6: 391–396PubMedCrossRefGoogle Scholar
  20. 20.
    Kotz R, Ramach W, Sigmund R, Wagner O (1982) Operative Therapie maligner Knochentumoren und Behandlungsergebnisse. Langenbecks Arch Chir 358: 387–392PubMedCrossRefGoogle Scholar
  21. 21.
    Nesbit ME, Gehan EA, Burgert EO et al. (1990) Multimodal therapy of primary nonmetastatic Ewing’s sarcoma of bone: a long-term follow-up of the First Intergroup Study. J Clin Oncol 8: 1664–1674PubMedGoogle Scholar
  22. 22.
    Paulussen M, Braun-Munzinger G, Burdach St, Deneke S, Dunst J, Fellinger E, Göbel U, Mittler U, Treuner J, Voûte PA, Winkler K, Jürgens H (1993) Behandlungsergebnisse beim ausschließlich pulmonal primär metastasierten Ewingsarkom. Eine retrospektive Analyse von 42 Patienten. Klin Pädiatr 205: 210–216PubMedCrossRefGoogle Scholar
  23. 23.
    Perez CA, Tefft M, Nesbit ME, Burgert EO, Vietti TJ, Kissane J, Pritchard DJ, Gehan EA (1981) Radiation therapy in the multimodal management of Ewing’s sarcoma of bone: report of the Intergroup Ewing’s Sarcoma Study. Natl Cancer Inst Monogr 56: 263–271PubMedGoogle Scholar
  24. 24.
    Price CHG, Jeffree GM (1977) Incidence of bone sarcomas in SW England, 1946–74, in relation to age, sex, tumour site and histology, Br J Cancer 36: 511–522Google Scholar
  25. 25.
    Pritchard DJ (1980) Indications for surgical treatment of localized Ewing’s sarcoma of bone. Clin Orthop 153: 39–43PubMedGoogle Scholar
  26. 26.
    Roessner A, Jürgens H (1993) Round cell tumors of bone. Path Res Pract 189: 1111–1136CrossRefGoogle Scholar
  27. 27.
    Roessner A, Jürgens H (1993) Neue Aspekte zur Pathologie des Ewing-Sarkoms. Osteologie 2: 57–73Google Scholar
  28. 28.
    Rosen G, Caparros B, Mosende C, McCormick B, Huvos AG, Marcove RC (1978) Curability of Ewing’s sarcoma and considerations for future therapeutic trials. Cancer 41: 888–899PubMedCrossRefGoogle Scholar
  29. 29.
    Rossi R, Danzebrink S, Hillebrand D, Linnenbürger K, Ullrich K, Jürgens H (1994) Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum. Medical and Pediatric Oncology 22: 27–32PubMedCrossRefGoogle Scholar
  30. 30.
    Rossi R, Gödde A, Kleinebrand A, Riepenhausen M, Boos J, Ritter J, Jürgens H (1994) Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: Analysis of 120 patients. J Clin Oncol 12: 159–165PubMedGoogle Scholar
  31. 31.
    Winkelmann W, Jürgens H (1989) Lokalkontrolle beim Ewing-Sarkom. Vergleichende Ergebnisse nach intraläsionaler, marginaler bzw. Tumorresektion im Gesunden. Z Orthop Grenzgeb 127: 424–426CrossRefGoogle Scholar
  32. 32.
    Zucker JM, Henry-Amar M, Sarazzin D, Blacke R, Platte C, Schweisguth O (1983) Intensive systemic chemotherapy in localized Ewing’s sarcoma in childhood. A historical trial. Cancer 52: 415–423PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • H. Jürgens

There are no affiliations available

Personalised recommendations